Back to Search Start Over

The Role of Nutraceuticals in Statin Intolerant Patients.

Authors :
UCL - (SLuc) Service de pathologie cardiovasculaire
Banach, Maciej
Patti, Angelo Maria
Giglio, Rosaria Vincenza
Cicero, Arrigo F G
Atanasov, Atanas G
Bajraktari, Gani
Bruckert, Eric
Descamps, Olivier
Djuric, Dragan M
Ezhov, Marat
Fras, Zlatko
von Haehling, Stephan
Katsiki, Niki
Langlois, Michel
Latkovskis, Gustavs
Mancini, G B John
Mikhailidis, Dimitri P
Mitchenko, Olena
Moriarty, Patrick M
Muntner, Paul
Nikolic, Dragana
Panagiotakos, Demosthenes B
Paragh, Gyorgy
Paulweber, Bernhard
Pella, Daniel
Pitsavos, Christos
Reiner, Željko
Rosano, Giuseppe M C
Rosenson, Robert S
Rysz, Jacek
Sahebkar, Amirhossein
Serban, Maria-Corina
Vinereanu, Dragos
Vrablík, Michal
Watts, Gerald F
Wong, Nathan D
Rizzo, Manfredi
International Lipid Expert Panel (ILEP)
UCL - (SLuc) Service de pathologie cardiovasculaire
Banach, Maciej
Patti, Angelo Maria
Giglio, Rosaria Vincenza
Cicero, Arrigo F G
Atanasov, Atanas G
Bajraktari, Gani
Bruckert, Eric
Descamps, Olivier
Djuric, Dragan M
Ezhov, Marat
Fras, Zlatko
von Haehling, Stephan
Katsiki, Niki
Langlois, Michel
Latkovskis, Gustavs
Mancini, G B John
Mikhailidis, Dimitri P
Mitchenko, Olena
Moriarty, Patrick M
Muntner, Paul
Nikolic, Dragana
Panagiotakos, Demosthenes B
Paragh, Gyorgy
Paulweber, Bernhard
Pella, Daniel
Pitsavos, Christos
Reiner, Željko
Rosano, Giuseppe M C
Rosenson, Robert S
Rysz, Jacek
Sahebkar, Amirhossein
Serban, Maria-Corina
Vinereanu, Dragos
Vrablík, Michal
Watts, Gerald F
Wong, Nathan D
Rizzo, Manfredi
International Lipid Expert Panel (ILEP)
Source :
Journal of the american college of cardiology : JACC, Vol. 72, no.1, p. 96-118 (2018)
Publication Year :
2018

Abstract

Statins are the most common drugs administered for patients with cardiovascular disease. However, due to statin-associated muscle symptoms, adherence to statin therapy is challenging in clinical practice. Certain nutraceuticals, such as red yeast rice, bergamot, berberine, artichoke, soluble fiber, and plant sterols and stanols alone or in combination with each other, as well as with ezetimibe, might be considered as an alternative or add-on therapy to statins, although there is still insufficient evidence available with respect to long-term safety and effectiveness on cardiovascular disease prevention and treatment. These nutraceuticals could exert significant lipid-lowering activity and might present multiple non-lipid-lowering actions, including improvement of endothelial dysfunction and arterial stiffness, as well as anti-inflammatory and antioxidative properties. The aim of this expert opinion paper is to provide the first attempt at recommendation on the management of statin intolerance through the use of nutraceuticals with particular attention on those with effective low-density lipoprotein cholesterol reduction.

Details

Database :
OAIster
Journal :
Journal of the american college of cardiology : JACC, Vol. 72, no.1, p. 96-118 (2018)
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1130438684
Document Type :
Electronic Resource